Trending Stock News

Shareholder Texas Capital Bancshares Boosted Jp Morgan Chase & Co (JPM) Position; As Gilead Sciences (GILD) Share Value Declined, Nbt Bank N A Lifted Holding

Texas Capital Bancshares Inc increased its stake in Jp Morgan Chase & Co (JPM) by 64.7% based on its latest 2017Q3 regulatory filing with the SEC. Texas Capital Bancshares Inc bought 3,215 shares as the company’s stock declined 6.04% while stock markets rallied. The institutional investor held 8,184 shares of the major banks company at the end of 2017Q3, valued at $781,000, up from 4,969 at the end of the previous reported quarter. Texas Capital Bancshares Inc who had been investing in Jp Morgan Chase & Co for a number of months, seems to be bullish on the $391.94 billion market cap company. The stock increased 0.10% or $0.11 during the last trading session, reaching $114.44. About 7.00M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since January 23, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Nbt Bank N A increased its stake in Gilead Sciences Inc (GILD) by 12.25% based on its latest 2017Q3 regulatory filing with the SEC. Nbt Bank N A bought 4,274 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 39,166 shares of the health care company at the end of 2017Q3, valued at $3.17 million, up from 34,892 at the end of the previous reported quarter. Nbt Bank N A who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $105.98 billion market cap company. The stock decreased 0.34% or $0.28 during the last trading session, reaching $81.13. About 4.06M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 23, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 16 have Buy rating, 2 Sell and 15 Hold. Therefore 48% are positive. JPMorgan Chase & Co had 107 analyst reports since July 21, 2015 according to SRatingsIntel. UBS upgraded JPMorgan Chase & Co. (NYSE:JPM) on Friday, February 5 to “Buy” rating. BMO Capital Markets maintained it with “Market Perform” rating and $91 target in Friday, October 13 report. The rating was maintained by Barclays Capital with “Overweight” on Tuesday, January 3. The company was upgraded on Tuesday, August 25 by Credit Agricole. The rating was downgraded by Macquarie Research on Friday, September 9 to “Neutral”. The rating was maintained by Jefferies with “Buy” on Monday, October 10. Jefferies maintained the stock with “Buy” rating in Tuesday, July 21 report. The firm earned “Buy” rating on Wednesday, February 24 by Jefferies. Nomura maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Wednesday, February 24. Nomura has “Neutral” rating and $67 target. The firm has “Neutral” rating given on Monday, January 11 by Goldman Sachs.

Investors sentiment decreased to 0.91 in 2017 Q3. Its down 0.28, from 1.19 in 2017Q2. It is negative, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Pacific Invest Mgmt holds 1.5% or 69,568 shares in its portfolio. Edgestream Prns Limited Partnership reported 4,525 shares or 0.23% of all its holdings. Bartlett Communications Limited Company holds 91,352 shares. Vestor Capital Limited Com owns 114,996 shares. Horrell Cap Mngmt holds 0.09% or 1,647 shares. Keybank National Association Oh holds 1.39% or 2.45 million shares. Oakwood Capital Ltd Ca accumulated 102,506 shares or 2.29% of the stock. Santa Barbara Asset Mgmt Ltd Llc invested in 3.55% or 2.33M shares. The Connecticut-based Benin Mngmt has invested 0.58% in JPMorgan Chase & Co. (NYSE:JPM). Brown Brothers Harriman Com has 0.02% invested in JPMorgan Chase & Co. (NYSE:JPM). State Of Wisconsin Board owns 4.17 million shares. Putnam Investments Ltd Company reported 8.09 million shares. Homrich Berg reported 22,331 shares. Duncker Streett & Communication invested in 1.25% or 43,264 shares. Northern Tru Corp holds 50.22M shares or 1.25% of its portfolio.

Since August 21, 2017, it had 1 buying transaction, and 10 insider sales for $23.24 million activity. On Wednesday, October 25 Friedman Stacey sold $214,019 worth of JPMorgan Chase & Co. (NYSE:JPM) or 2,099 shares. Scher Peter sold $3.01M worth of stock. Lake Marianne had sold 9,194 shares worth $1.03 million on Saturday, January 13. The insider BACON ASHLEY sold 16,434 shares worth $1.84M. 65,101 shares valued at $7.31 million were sold by Erdoes Mary E. on Saturday, January 13. Another trade for 48,344 shares valued at $5.43M was sold by Petno Douglas B.

Nbt Bank N A, which manages about $625.68 million US Long portfolio, decreased its stake in Microsoft Corp (NASDAQ:MSFT) by 14,547 shares to 208,424 shares, valued at $15.53 million in 2017Q3, according to the filing. It also reduced its holding in Pepsico Inc (NYSE:PEP) by 5,172 shares in the quarter, leaving it with 102,597 shares, and cut its stake in Procter & Gamble Co (NYSE:PG).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 112 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $87.0 target in Friday, October 27 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Friday, April 29 by Citigroup. Bank of America upgraded Gilead Sciences, Inc. (NASDAQ:GILD) rating on Friday, January 15. Bank of America has “Neutral” rating and $107.0 target. Mizuho maintained the stock with “Buy” rating in Tuesday, July 25 report. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, July 29. Jefferies maintained the stock with “Hold” rating in Tuesday, March 15 report. On Wednesday, October 28 the stock rating was maintained by Maxim Group with “Buy”. As per Wednesday, October 18, the company rating was maintained by Cowen & Co. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Wednesday, June 14 by William Blair. The firm earned “Buy” rating on Thursday, February 25 by Citigroup.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It increased, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. 27.71 million were reported by Fmr Llc. Security National holds 28,793 shares or 0.77% of its portfolio. Arvest Retail Bank Division reported 239,662 shares. Cubic Asset Mgmt has invested 0.69% in Gilead Sciences, Inc. (NASDAQ:GILD). Hilltop Holdg Incorporated has 3,173 shares for 0.08% of their portfolio. Tru Department Mb Bancshares N A, Illinois-based fund reported 71,904 shares. Ci Investments Inc, a Ontario – Canada-based fund reported 59,658 shares. 5,695 are owned by Signaturefd Ltd Liability Corporation. Trust Of Oklahoma invested 0.35% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Rafferty Asset Mngmt Lc has 0.03% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 18,984 shares. Citigroup has 1.36 million shares for 0.09% of their portfolio. The New York-based Orbimed Advsrs Ltd Liability Com has invested 1.49% in Gilead Sciences, Inc. (NASDAQ:GILD). Brookmont Mgmt invested 1.92% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). First Citizens Bancorporation & Tru owns 5,135 shares. Fjarde Ap holds 305,507 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *